Ablation catheters and associated systems and methods
An ablation catheter assembly including an elongate catheter body having a proximal portion, a distal portion and a lumen therethrough. A helical structure associated with the catheter distal portion carries a plurality of independently operable electrodes and is transformable between a low-profile configuration wherein a straightening element is positioned in the lumen and an expanded configuration wherein the straightening element is at least partially retracted from the spiral structure. When the helical structure is in the expanded configuration, a laterally offset tip portion extends distally therefrom.
Latest Medtronic, Inc. Patents:
- Rate smoothing to enhance atrial synchronous pacing in a ventricular pacemaker
- Pacing mode switching and rate response limit in a ventricular pacemaker
- Method and apparatus for atrial arrhythmia episode detection
- Unwrapped 2D view of a stimulation lead with complex electrode array geometry
- Interventional medical devices, device systems, and fixation components thereof
This application is a continuation of U.S. Patent App. No. 13/560,942, filed
Jul. 27, 2012, now U.S. Patent No. 8,834,464, which is a continuation of U.S. patent application Ser. No. 12/760,807, filed Apr. 15, 2010, now U.S. Pat. No. 8,257,351 which is a divisional of U.S. patent application Ser. No. 10/655,197, filed Sep. 4, 2003, now U.S. Pat. No. 7,771,421, which is a divisional of U.S. patent application Ser. No. 09/848,555, filed May 3, 2001, now U.S. Pat. No. 6,702,811, which is a continuation-in-part of U.S. patent application Ser. No. 09/733,356, filed Dec. 8, 2000, now abandoned, which is a continuation-in-part of U.S. Pat. No. 6,325,797, filed Apr. 5, 1999. All of the foregoing applications are incorporated herein by reference in their entireties.
BACKGROUND OF THE INVENTIONThe present invention relates to an ablation catheter for treatment of cardiac arrhythmia, for example atrial fibrillation. More particularly, it relates to an ablation catheter configured to electrically isolate portions or an entirety of a vessel, such as a pulmonary vein, from a chamber, such as the left atrium, with a lesion pattern and a method for forming such a lesion pattern.
The heart includes a number of pathways that are responsible for the propagation of signals necessary to produce continuous, synchronized contractions. Each contraction cycle begins in the right atrium where a sinoatral node initiates an electrical impulse. This impulse then spreads across the right atrium to the left atrium, stimulating the atria to contract. The chain reaction continues from the atria to the ventricles by passing through a pathway known as the atrioventricular (AV) node or junction, which acts as an electrical gateway to the ventricles. The AV junction delivers the signal to the ventricles while also slowing it, so the atria can relax before the ventricles contract.
Disturbances in the heart's electrical system may lead to various rhythmic problems that can cause the heart to beat irregularly, too fast or too slow. Irregular heart beats, or arrhythmia, are caused by physiological or pathological disturbances in the discharge of electrical impulses from the sinoatrial node, in the transmission of the signal through the heart tissue, or spontaneous, unexpected electrical signals generated within the heart. One type of arrhythmia is tachycardia, which is an abnormal rapidity of heart action. There are several different forms of atrial tachycardia, including atrial fibrillation and atrial flutter. With atrial fibrillation, instead of a single beat, numerous electrical impulses are generated by depolarizing tissue at one or more locations in the atria (or possibly other locations). These unexpected electrical impulses produce irregular, often rapid heartbeats in the atrial muscles and ventricles. Patients experiencing atrial fibrillation may suffer from fatigue, activity intolerance, dizziness and even strokes.
The precise cause of atrial fibrillation, and in particular the depolarizing tissue causing “extra” electrical signals, is currently unknown. As to the location of the depolarizing tissue, it is generally agreed that the undesired electrical impulses often originate in the left atrial region of the heart. Recent studies have expanded upon this general understanding, suggesting that nearly 90% of these “focal triggers” or electrical impulses are generated in one (or more) of the four pulmonary veins (PV) extending from the left atrium. In this regard, as the heart develops from an embryotic stage, left atrium tissue may grow or extend a short distance into one or more of the PVs. It has been postulated that this tissue may spontaneously depolarize, resulting in an unexpected electrical impulse(s) propagating into the left atrium and along the various electrical pathways of the heart.
A variety of different atrial fibrillation treatment techniques are available, including drugs, surgery, implants, and catheter ablation. While drugs may be the treatment of choice for some patients, drugs typically only mask the symptoms and do not cure the underlying cause. Implantable devices, on the other hand, usually correct an arrhythmia only after it occurs. Surgical and catheter-based treatments, in contrast, will actually cure the problem by ablating the abnormal tissue or accessory pathway responsible for the atrial fibrillation. The catheter-based treatments rely on the application of various destructive energy sources to the target tissue, including direct current electrical energy, radiofrequency electrical energy, laser energy, and the like. The energy source, such as an ablating electrode, is normally disposed along a distal portion of a catheter.
Most ablation catheter techniques employed to treat atrial fibrillation focus upon locating the ablating electrode, or a series of ablating electrodes, along extended target sections of the left atrium wall. Because the atrium wall, and thus the targeted site(s), is relatively tortuous, the resulting catheter design includes multiple curves, bends, extensions, etc. In response to recent studies indicating that the unexpected electrical impulses are generated within a PV, efforts have been made to ablate tissue within the PV itself. Obviously, the prior catheter designs incorporating convoluted, multiple bends are not conducive to placement within a PV. Instead, a conventional “straight ended” ablation catheter has been employed. While this technique of tissue ablation directly within a PV has been performed with relatively high success, other concerns may arise.
More particularly, due to the relatively small thickness of atrial tissue formed within a PV, it is likely that ablation of this tissue may in fact cause the PV to shrink or constrict. Because PV's have a relatively small diameter, a stenosis may result. Even further, other vital bodily structures are directly adjacent each PV. These structures may be undesirably damaged when ablating within a PV.
In light of the above, an alternative technique has been suggested whereby a continuous ablation lesion pattern is formed in the left atrium wall about the ostium associated with the PV in question. In other words, the PV is electrically isolated from the left atrium by forming an ablation lesion pattern that surrounds the PV ostium. As a result, any undesired electrical impulse generated within the PV could not propagate into the left atrium, thereby eliminating unexpected atria contraction.
Unfortunately, while PV isolation via a continuous ablation lesion pattern about the PV ostium appears highly viable, no acceptable ablation catheter configuration exists. Most atrial fibrillation ablation catheters have linear distal ends, designed for manipulation in a sliding fashion along the atrial wall. That is to say, the distal, electrode-carrying end of the catheter is typically slid along (or parallel to) the atrial wall. With this generally accepted configuration in mind, it may be possible to shape the distal, electrode-carrying end into a small ring sized in accordance with the PV ostium. For example, U.S. Pat. No. 5,617,854 discloses one such possibility. More particularly, the described ablation catheter includes a substantially ring-shaped portion sized to contact the ostium of the coronary sinus. Pursuant to conventional designs, the ring extends linearly from the catheter body. In theory, the ring-shaped portion may be placed about a PV ostium. However, proper positioning would be extremely difficult and time consuming. More particularly, it would be virtually impossible to locate and then align the ring about a PV ostium when sliding the catheter along the atrium wall. The ring must be directed toward the ostium in a radial direction (relative to a central axis of the ostium). Even if the electrophysiologist were able to direct the ring to the ostium, the periodic blood flow through the PV would likely force the ring away from the atrium wall, as the catheter body would not provide any support.
A related concern entails mapping of a PV prior to ablation. In cases of atrial fibrillation, it is necessary to identify the origination point of the undesired electrical impulses prior to ablation. Thus, it must first be determined if the electrical impulse originates within one or more PVs. Once the depolarizing tissue has been identified, necessary ablation steps can be taken. Mapping is normally accomplished by placing one or more mapping electrodes into contact with the tissue in question. In order to map tissue within a PV, therefore, a relatively straight catheter section maintaining two or more mapping electrodes must be extended axially within the PV. Ablation catheters configured to slide along the atrial wall cannot include a separate, distal extension for placement within the PV. Instead, an entirely separate mapping catheter must be provided and then removed for subsequent replacement with the ablation catheter. Obviously, these additional steps greatly increase the overall time required to complete the procedure.
Electrical isolation of a pulmonary vein via an ablation lesion pattern surrounding the pulmonary vein ostium presents a potentially revolutionary technique for treatment of atrial fibrillation. However, the unique anatomical characteristics of a pulmonary vein and left atrium render currently available ablation catheters minimally useful. Therefore, a substantial need exists for an ablation catheter designed for consistent positioning of one or more ablation electrodes about a pulmonary vein ostium, as well as for providing pulmonary vein mapping information.
SUMMARYOne aspect of the present invention provides a catheter assembly for treatment of cardiac arrhythmia. The catheter assembly includes a catheter body and an ablative energy source. The catheter body includes a proximal portion, an intermediate portion, and a distal portion. The intermediate portion extends from the proximal portion and defines a longitudinal axis. The distal portion extends from the intermediate portion and includes an ablation section and a tip. The ablation section forms a loop defining a diameter greater than an outer dimension of a pulmonary vein ostium. The tip extends distally from the ablation section and is configured to locate a pulmonary vein. Finally, the ablative energy source is associated with the ablation section. With this configuration, upon activation of the energy source, the ablation section ablates a desired lesion pattern. In one preferred embodiment, the ablation section forms a distally decreasing radius helix, whereas the tip includes a relatively linear leader section. With this one preferred configuration, the tip readily locates a pulmonary vein and guides the ablation section to a seated relationship about a pulmonary vein ostium.
Another aspect of the present invention relates to a catheter assembly for electrically isolating a vessel from a chamber for treatment of cardiac arrhythmia. The catheter assembly includes a catheter body and an ablative energy source. The catheter body includes a proximal portion, an intermediate portion, and a distal portion. The intermediate portion extends from the proximal portion and defines a longitudinal axis. The distal portion extends from the intermediate portion and includes an ablation section and a tip. The ablation section forms a loop. The tip extends distally from the ablation section and is configured to locate a vessel. Further, the tip is characterized as having a feature different from that of the ablation section. In particular, the tip has either a different shape, material, durometer, or porosity as compared to the ablation section. Finally, the ablative energy source is associated with the ablation section. With this configuration, upon activation of the energy source, the ablation section ablates a desired lesion pattern. By forming the tip to have a feature different from that of the ablation section, the catheter assembly more readily locates a vessel, such as a pulmonary vein, and seats the ablation section about the vessel ostium, thereby promoting a properly located and uniform ablation pattern. In one preferred embodiment, the ablation section is formed of a microporous polymer, whereas the tip is impervious to fluid flow. With this configuration, fluid is irrigated to an exterior of the ablation section and then energized to ablate the tissue.
Yet another aspect of the present invention relates to a catheter assembly for electrically isolating a vessel from a chamber for treatment of cardiac arrhythmia. The catheter assembly includes a catheter body and an ablative energy source. The catheter body includes a proximal portion, an intermediate portion, and a distal portion. The intermediate portion extends from the proximal portion and defines a longitudinal axis. The distal portion extends from the intermediate portion and includes an ablation section and a tip. The ablation section forms a loop transverse to the longitudinal axis. The tip extends distally from the ablation section and defines a shape different from a shape defined by the ablation section. Finally, the ablative energy source is associated with the ablation section. With this configuration, upon activation of the energy source, the ablation section ablates a desired lesion pattern. In one preferred embodiment, the ablation section and the tip define different distally decreasing radius helixes.
Yet another aspect of the present invention relates to a method of electrically isolating a vessel from a chamber for treatment of cardiac arrhythmia. In this regard, the vessel forms an ostium at a wall of the chamber. With this in mind, the method includes selecting a catheter assembly including a catheter body and an ablative energy source. The catheter body includes a proximal portion and a distal portion, with the distal portion including an ablation section and a tip. The ablation section forms a loop and the tip extends distally from the ablation section. Further, the ablative energy source is associated with the ablation section. The distal portion of the catheter body is then guided into the chamber. The vessel is located with the tip. The distal portion is then advanced such that the ablation section contacts the chamber wall about the vessel ostium. In this regard, interaction between the tip and the vessel properly positions the ablation section relative to the vessel ostium as the distal portion is advanced. Finally, the ablative energy source is activated to ablate a desired lesion pattern about at a portion of at least a portion of the ostium to electrically isolate the vessel from the chamber. In one preferred embodiment, the tip is prevented from ablating the vessel during activation of the ablative energy source.
One preferred embodiment of a catheter assembly 20 in accordance with the present invention is shown in
The catheter body 22 is defined by a proximal portion 28, an intermediate portion 30 and a distal portion 32, and includes a central lumen (not shown). Although not specifically shown, the catheter body may be configured for over-the-wire or rapid exchange applications. In one preferred embodiment, the proximal portion 28, the intermediate 30 and the distal portion 32 are integrally formed from a biocompatible material having requisite strength and flexibility for deployment within a heart. Appropriate materials are well known in the art and include polyamide.
The intermediate portion 30 extends from the proximal portion 28. The proximal portion 28 and the intermediate portion 30 are preferably flexible, so as to facilitate desired articulation during use. In general terms, however, the intermediate portion 30 defines a longitudinal axis L1. It should be recognized that in one position (shown in
The distal portion 32 extends from the intermediate portion 30 and forms a loop 34. In one preferred embodiment, the loop 34 is circular, formed in a plane transverse to the longitudinal axis L1. To this end, the distal portion 32 preferably includes a lateral segment 36. The lateral segment 36 extends in a generally lateral fashion from the intermediate portion 30. The loop 34 extends from the lateral segment 36 in an arcuate fashion, turning or revolving about a central loop axis C1 (shown best in
As best shown in
Regardless of the exact shape, the loop 34 preferably defines an enclosed area A greater than a size of an ostium (not shown) associated with a particular vessel to be isolated, as described in greater detail below. In one preferred embodiment, the catheter assembly 20 is configured to electrically isolate a pulmonary vein from the left atrium. With this one preferred application, where the loop 34 is circular, the loop 34 has a diameter in the range of approximately 10-20 mm, more preferably 15 mm, although other sizes, either greater or smaller, are acceptable.
The loop 34 may be formed in a variety of ways, such as by incorporating a preformed section of super elastic, shape memory material, such as Nitinol, with a loop configuration. To facilitate guiding of the distal portion 32 into a heart (not shown), the catheter assembly 20 may include a stylet (not shown) internally disposed within the catheter body 22. In an extended position, the stylet would extend through the distal portion 32, so as to render the loop 34 straight. Upon retraction of the stylet, the distal portion 32 would form the loop 34. Alternatively, the catheter assembly 20 may include a sheath (not shown) slidably receiving the catheter body 22. Prior to deployment, the distal portion 32 would be retracted within the sheath, rendering the loop 34 straight. Upon deployment from the sheath, the distal portion 32 would form the loop 34. Other similar approaches for providing the loop 34 are similarly acceptable.
The handle 24 is preferably sized to be grasped by a user and includes an electrical connector 44. The electrical connector provides electrical connections to the electrodes 26 carried by the distal portion 32. To this end, wire(s) (not shown) may extend within the central lumen (not shown) from the distal portion 32 to the handle 24.
The electrodes 26 are preferably of a type known in the art and are preferably a series of separate band electrodes spaced along the loop 34. Instead of, or in addition to, separate band electrodes, the electrodes 26 may include one or more spiral or coil electrodes, or one or more counter-electrodes. Additionally, the electrodes 26 are preferably non-thrombogenic, non-coagulum or char forming. The electrodes 26 may be cooled by a separate source (not shown), such as a saline source. The electrodes 26 may be electrically isolated from one another, or some or all of the electrodes 26 may be electrically connected to one another. Preferably, however, at least one electrode 26 is provided. The electrodes 26 are preferably shaped and positioned such that during an ablation procedure, a continuous, closed therapeutically-effective lesion pattern is created. Preferably, the length of each of the electrodes 26 is about 4-12 mm, more preferably about 7 mm. The spacing between each of the electrodes 26 is preferably about 1-3 mm, and more preferably about 2 mm. Finally, to effectuate a continuous, closed lesion pattern, preferably one of the electrodes 26 is disposed at the proximal end 40 of the loop 34, and another of the electrodes 26 is disposed at the distal end 42. As previously described, it is not necessary that the loop segment 38 be formed such that the proximal end 40 and the distal end 42 are integral. Instead, a slight spacing may exist. With this in mind, the spacing or gap between the electrode 26 at the proximal end 40 and the electrode 26 at the distal end 42 is preferably less than about 5 mm.
As shown in
The electrodes 26 (shown best in
The continuous, closed lesion pattern electrically isolates the pulmonary vein PV from the left atrium LA. Any undesired electrical impulses generated in the pulmonary vein are effectively “stopped” at the lesion pattern, and will not propagate into the left atrium LA.
An alternative catheter assembly 60 is shown in
Similar to the catheter body 22, the intermediate portion 66 extends from the proximal portion and defines a longitudinal axis L2. The distal portion 68 extends from the intermediate portion 66 and forms a loop or coil 70 substantially transverse to the longitudinal axis L2 and includes a plurality of loop segments 72A-72C. The coil 70 is formed such that each of the loop segments 72A-72C revolves about a central loop axis C2. In one preferred embodiment, the central loop axis C2 is aligned with the longitudinal axis L2 defined by the intermediate portion 66. Alternatively, the central loop axis C2 may be offset from the longitudinal axis L2. Regardless, the central loop axis C2 is preferably substantially parallel with the longitudinal axis L2.
Each of the loop segments 72A-72C preferably defines a different diameter. For example, the first loop segment 72A defines a diameter slightly larger than that of the second loop segment 72B; whereas the second loop segment 72B defines a diameter slightly greater than that of the third loop segment 72C. In this regard, while each of the loop segments 72A-72C are depicted as being longitudinally spaced (such that the loop 70 forms a multi-lane spiral or coil), the loop segments 72A-72C may instead be formed in a single plane (such that the loop 70 forms a unitary plane spiral or coil). While the loop segments 72A-72C extend distal the intermediate portion 66 so as to define a descending or decreasing diameter, an opposite configuration may also be employed. For example,
Returning to
The catheter assembly 60 is used in a fashion highly similar to the method previously described for the catheter assembly 20 (as shown, for example, in
Another alternative embodiment of a catheter assembly 80 is shown in
Catheter body 82 is defined by a proximal portion (not shown), an intermediate portion 88 and a distal portion 90. The intermediate portion 88 extends from the proximal portion and is defined by a proximal segment 92 and a distal segment 94. In a preferred embodiment, the distal segment 94 is preferably more flexible than the proximal segment 92. With this configuration, the distal segment 94 can more easily deflect relative to the proximal segment 92, thereby facilitating desired positioning of the distal portion 90 during deployment. In this regard, an internal pull wire (not shown) may be provided to effectuate desired deflection of the distal segment 94. Even further, an anchor 96 is preferably included for facilitating a more radical displacement of the distal portion 90 relative to the intermediate portion 88.
As with previous embodiments, the intermediate portion 88 defines a longitudinal axis L3. Once again, where the intermediate portion 88 is axially aligned with the proximal portion (not shown), the longitudinal axis L3 is linear along the intermediate portion 88 and the proximal portion. However, because the intermediate portion 88 is preferably bendable relative to the proximal portion, and further because the distal segment 94 may bend relative to the proximal segment 92, the longitudinal axis L3 is more succinctly defined by the intermediate portion 88 at the point of intersection between the intermediate portion 88 and the distal portion 90.
Similar to the catheter assembly 20 (
The electrode 84 is shown in
Finally, the locating device 86 includes a tip 104 configured to extend distal the loop 98. In one preferred embodiment, the locating device 86 is integrally formed with the catheter body 82, extending from the distal portion 90. Alternatively, the locating device 86 may be a separate body. Regardless, the tip 104 extends distal the distal portion 90, and is aligned with the central loop axis C3 defined by the loop 98. The tip 104 preferably has a diameter less than a diameter of a pulmonary vein, and a length in the range of approximately 1-15 mm. Further, as shown in
As shown in
Yet another alternative embodiment of a catheter assembly 110 in accordance with the present invention is shown in
The locating device 116 includes a tip 124 that extends distal the loop 122. In one preferred embodiment, the locating device 116 is integrally formed with the catheter body 112 and includes mapping electrodes 126 connected to an external recording device (not shown). Alternatively, the locating device 116 may be a separate body. As shown in
It should be recognized that other devices can be provided to assist in centering the ablation loop about the pulmonary vein ostium. For example, yet another alternative embodiment of a catheter assembly 130 is depicted in
During use, the locating device 138 is used to locate a pulmonary vein PV (
Yet another alternative embodiment of a catheter assembly 160 is shown in
The wire basket 166 is maintained by the distal portion 172 distal the loop 174. The wire basket 166 may be radially extended and retracted via a pull wire or similar activation device extending through a lumen (not shown) formed within the catheter body 162.
Finally, the locating device 168 includes a tip 176 positioned distal the loop 174. In one preferred embodiment, the locating device 168 is integrally formed with the catheter body 162 and includes mapping electrodes 178. Alternatively, the locating device 168 may be a separate body, and the tip 176 may be disposed between the wire basket 166 and the loop 174.
During use, the catheter assembly 160 functions in a fashion highly similar to the catheter assembly 130 (
Yet another alternative embodiment of a catheter assembly 190 is shown in
The catheter body 192 is virtually identical to the catheter body 62 (
The electrodes 194 are identical to those previously described and preferably comprise band electrodes disposed along the coil 204. Alternatively, a continuous coil electrode or counter-electrode may be provided.
The locating device 196 is relatively rigid and includes a shaft 206 defining a tip 208 that preferably maintains mapping electrodes 210. The shaft 206 is sized to be slidably received within a lumen (not shown) in the sheath 198. As shown in
The sheath 198 includes a proximal end (not shown) and a distal end 212, and forms at least one central lumen (not shown) sized to maintain the catheter body 192 and the locating device 196. Alternatively, a separate lumen may be provided for each of the catheter body 192 and the locating device 196. Regardless, the sheath 198 is configured to slidably maintain each of the catheter body 192 and the locating device 196 in a relatively close relationship. In one preferred embodiment, the sheath 198 is formed of a relatively soft material such as 35D or 40D Pebex.
As described above, each of the catheter body 192 and the locating device 196 are slidable relative to the sheath 198. In a deployed position (depicted in
During use, the catheter body 192 and the locating device 196 are retracted within the sheath 198. The sheath 198 is then guided to the left atrium LA (
While the catheter assembly 190 has been described as including the sheath 198 to maintain the catheter body 192 and the locating device 196, the sheath 198 may be eliminated for example, the catheter body 192 may alternatively be configured to include lumen (not shown) sized to slidably receive the locating device 196. In this regard, the locating device 196 may serve as a guide wire, with the catheter body 192 riding over the locating device 196 much like an over-the-wire catheter configuration commonly known in the art. Even further, the catheter body 192 may include a rapid exchange design characteristic for quick mounting to removal from the locating device 196.
Yet another alternative embodiment of a catheter assembly 220 is shown in
The catheter body 222 is similar to those previously described and includes a proximal portion (not shown), an intermediate portion 230, defining a longitudinal axis L8, and a distal portion 232. The distal portion 232 forms a loop 234 substantially transverse to the longitudinal axis L8. The loop 234 revolves around a central loop axis C8 which, in one preferred embodiment, is aligned with the longitudinal axis L8. The distal portion 232 is preferably sufficiently flexible so as to be relatively straight in a retracted position (
Each of the stylets 226 are relatively rigid shafts sized to be slidably received within lumens (not shown) formed by the catheter body 222. To this end, as shown in
The electrodes 224 are identical to those previously described and preferably comprise band electrodes disposed along the loop 234. Alternatively, a continuous coil electrode or counter electrode may be provided.
The locating device 228 includes a shaft 236 having a tip 238. Similar to previous embodiments, the tip 238 is preferably coil shaped, and includes mapping electrodes 240. In this regard, the tip 238 is preferably sufficiently flexible such that in the retracted position (
The catheter assembly 220 is used in a manner highly similar to that previously described. The catheter assembly 220 is initially placed in the retracted position (
Yet another alternative embodiment of the catheter assembly 250 in accordance with the present invention is shown in
The catheter body 252 is virtually identical to the catheter body 62 (
The electrodes 254 are identical to those previously described and preferably comprise band electrodes disposed along the coil 264. Alternatively, a continuous coil electrode or counter-electrode may be provided.
The locating device 256 includes a shaft 266 and a balloon 268. The shaft 266 includes a distal portion 270 and a tip 272. The distal portion 270 preferably forms an expansion joint 274. The tip 272 is distal the expansion joint 274 and preferably maintains mapping electrodes 276. The balloon 268 is sealed to the distal portion 270 of the shaft 266 about the expansion joint 274. In this regard, the expansion joint 274 is configured to be manipulated between a contracted position (
The sheath 258 includes a proximal end (not shown) and a distal end 278, and forms at least one central lumen (not shown) sized to maintain the catheter body 252 and the locating device 256. Alternatively, a separate lumen may be provided for each of the catheter body 252 and the locating device 256. Regardless, the sheath 258 is configured to slidably maintain each of the catheter body 252 and the locating device 256 in relatively close relationship. In one preferred embodiment, the sheath 258 is formed of a relatively soft material such as 35D or 40D Pebex.
As described above, each of the catheter body 252 and the locating device 256 are slidable relative to the sheath 258. In a deployed position (depicted in
Prior to use, the catheter body 252 and the locating device 256 are retracted within the sheath 258. The sheath 258 is then guided to the left atrium LA (
Yet another alternative embodiment of a catheter assembly 290 is shown in
The catheter body 292 includes a proximal portion (not shown), an intermediate portion 300 defining a longitudinal axis L10 and a distal portion 302. The distal portion 302 extends from the intermediate portion 300 and forms a coil or plurality of loops 304 substantially transverse to the longitudinal axis L10. Alternatively, the coil 304 may form a single loop. The coil 304 revolves around a central loop axis C10, that, in one preferred embodiment, is aligned with the longitudinal axis L10. The distal portion 302, and in particular the coil 304, is preferably sufficiently flexible so as to assume a relatively straight configuration when retracted within the sheath 298. Further, the distal portion 302 includes a shape memory characteristic such that when deployed from the sheath 298, the distal portion 302 forms the coil 304 as shown in
The electrodes 294 are identical to those previously described and preferably comprise band electrodes disposed along the coil 304. Alternatively, a continuous coil electrode or counter-electrode may be provided.
The locating device 296 includes a shaft 306 and a wire basket 308. The shaft 306 includes a distal portion 310 and a tip 312. The distal portion 310 forms an expansion joint 314. The tip 312 preferably maintains mapping electrodes 316. The wire basket 308 is secured to the distal portion 310 about the expansion joint 314. With this configuration, the expansion joint 314 can be manipulated between an expanded position in which the wire basket 308 is relatively flat and a contracted position (
The sheath 298 is highly similar to previous embodiments and includes a proximal end (not shown) and a distal end 318, and forms at least one central lumen (not shown) sized to maintain the catheter body 292 and the locating device 296. Alternatively, a separate lumen may be provided for each of the catheter body 292 and the locating device 296. Regardless, the sheath 298 is configured to slidably maintain each of the catheter body 292 and the locating device 296 in a relatively close relationship.
As described above, each of the catheter body 292 and the locating device 296 are slidable relative to the sheath 298. In a deployed position (depicted in
During use, the catheter assembly 290 functions in a manner highly similar to the catheter assembly 250 (
Yet another alternative embodiment of the catheter assembly 330 is shown in
The catheter body 332 includes a proximal portion (not shown), an intermediate portion 342 defining a longitudinal axis L11 and a distal portion 344. The distal portion 344 maintains a proximal collar 346 and a distal collar 348. In a preferred embodiment, the proximal collar 346 is slidable relative to the distal collar 348.
The wire basket 334 is secured to the distal portion 344 by the proximal collar 346 and the distal collar 348. Further, the wire basket 334 includes a plurality of individual wire struts 350 each maintaining an electrode 352. In a preferred embodiment, the wire struts 350 are preferably tubular and are fluidly connected to a cooling source. The electrodes 352 are preferably disposed along the wire struts 350, respectively, slightly distal of a central position. With this configuration, the wire basket 334 can be maneuvered between a retracted position (
The electrodes 352 are identical to those previously described and preferably comprise band electrodes disposed along the wire basket 334.
The locating device 336 extends distal the distal collar 348, and maintains the balloon 340 and mapping electrodes 354. The balloon 340 is fluidly connected to an inflation source (not shown) by a lumen (not shown) formed within the catheter body 332. As shown in
Prior to use, the catheter assembly 330 is positioned in the retracted position shown in
Yet another alternative embodiment of a catheter assembly 400 is shown in
The fluid source 404 is shown schematically in
The catheter body 402 includes a proximal portion 416, an intermediate portion 418, and a distal portion 420. Construction of the catheter body 402 is described in greater detail below. In general terms, and as shown in
With additional reference to
The second lumen 430 extends from the proximal portion 416 to the distal portion 420, preferably terminating at an opening 434 located proximal the ablation section 422. This relationship is illustrated in
The catheter body 402 is described in greater detail with reference to
Use of a porous material for the ablation section 422 establishes a plurality of pores 440 extending from an interior surface 442 to an exterior surface 444. As shown in
While the ablation section 422 has been preferably described as being formed of a microporous polymer, other constructions are equally acceptable. For example, as shown in
Regardless of exact construction, in a preferred embodiment the distal portion 420, including the ablation section 422, is preferably compliant, and can readily be manipulated to a desired shape. To this end, the shaping wire 406 is preferably employed to selectively direct the distal portion 420 to the helical or coiled configuration of
Returning to
The shaping wire 406 is shown in greater detail in
The shaping wire 406, and in particular the distal segment 466, is preferably formed of a thin material having a super elasticity or shape memory characteristic. For example, in one preferred embodiment, the shaping wire 406 is formed from spring-like material such as super elastic or pseudo-elastic nickel titanium (commercially available as Nitinol material), having a diameter in the range of approximately 0.010-0.020 inch (0.25-0.5 mm). With this or other resilient material (such as stainless steel or resilient plastic), the desired helical configuration of the distal segment 466 is imparted during formation of the shaping wire 406. As a result, the distal segment 466 has a highly resilient, spring-like attribute whereby the distal segment 466 can be “forced” to the straightened state of
The metal wire 470 is wound about a portion of the distal segment 466 to form a coil electrode 474 and is secured to the shaping wire 406, such as by a weld 472. Further, the metal wire 470 extends to the proximal segment (not shown) where it is electrically connected to a power source (not shown), for example a source of radio frequency (RF) energy. The location and length of the coil electrode 474 relative to the shaping wire 406 corresponds with a location and length of the ablation section 422 (
While the shaping wire 406 has been described as carrying a single metal wire 470, and thus a single coil electrode 474, multiple wires/coil electrodes can be provided. For example, in a more preferred embodiment, depicted in
Returning to
Finally, the distal section 482 can be formed to include a J-shaped or floppy tip to facilitate placement within a vein. As described below with reference to an alternative embodiment, the guide wire 408 is not a necessary element, and can be replaced with an alternative locating device.
Finally, the sensing electrode pairs 410a, 410b are preferably band electrodes capable of providing feed back information indicative of electrical activity. As described below, the sensing electrode pairs 410a, 410b are useful for evaluating the “completeness” of an ablation pattern formed by the catheter assembly 400. To this end, the sensing electrode pairs 410a, 410b are strategically located along the distal portion 420 relative to the ablation section 422. It will be noted that the distal portion 420 is preferably helically-shaped, having a decreased diameter proximal the ablation section 422, and an increased diameter distal the ablation section 422. With this in mind, the first sensing electrode pair 410a is preferably located proximal the ablation section 422 for evaluating electrical activity “within” the loop pattern defined by the ablation section 422. Conversely, the second sensing electrode pair 410b is distal the ablation section 422 for evaluating electrical activity “outside” the loop. With alternative embodiments, one or both of the sensing electrode pairs 410a, 410b can be eliminated; or additional sensing electrodes provided. Even further, additional sensors, such as a thermocouple, can be included along the distal portion 420.
The catheter assembly 400 of
Following the preparatory steps, and with reference to
Following deployment of the catheter body 402, the guide wire 408 is then deployed as illustrated in
Once deployed, the guide wire 408 is utilized to locate the left pulmonary vein LPV to be treated. In this regard, a fluoroscope is preferably employed to provide visual confirmation that the guide wire 408 is positioned within the left pulmonary vein LPV to be isolated.
The catheter body 402 is advanced over the guide wire 408 and into contact with the left atrium LA tissue wall/material surrounding the pulmonary vein ostium PVO as shown in
The fluid flow rate from the fluid source (not shown) to the ablation section 422 is then increased to approximately 4-10 ml/min. After waiting for a short period to ensure increased fluid flow to, and irrigation through, the ablation section 422, the coil electrode 474 (
Following application of the ablation energy, the catheter assembly 400 is preferably operated to determine whether a closed, electrically isolating ablation pattern has been established in the chamber wall, about or outside of the ostium PVO. More particularly, and as shown in
As should be evident from the views of
Controls and structures useful in providing this steering capability are well-known in the art, and can include a stiffening wire or pulling wire extending along the guide catheter 486. Alternatively and/or in addition, the catheter body 402 may be provided with a steering device to facilitate selective deflection of the distal portion 420 relative to a remainder of the catheter body 402.
The preferred implementation of the shaping wire 406 (
Alternatively, as shown in
Another alternative, more preferred embodiment of a catheter assembly 550 is shown in
The delivery catheter 552 is shown in greater detail in
In light of the preferred steerable attribute of the delivery catheter 552, the proximal region 570 includes a Y-connector 574 coupled to a handpiece 576 and a guide piece 578. The handpiece 576 is of a type known in the art and provides control devices 580, the operation of which effectuates desired bending of the delivery catheter 552 via pull wires (not shown) described in greater detail below. The guide piece 578 is fluidly connected to the delivery lumen 558 (
With further reference to
The proximal region 570 is preferably formed of a reinforced, braided material such as a tubular shaft constructed of amorphous thermoplastic polyetherimide (PEI) materials sold under the trademark ULTEM, polyamide, or other high temperature polymer covered with a reinforcing braid wire or high strength filament and jacketed by a flexible polymer such as nylon, polyurethane, or polyether block amide sold under the trademark PEBAX. With this preferred material, the proximal region 570 exhibits enhanced torqueability, such that a user can more easily steer or guide the delivery catheter 552 to a target site.
The intermediate region 572 forms the opening 560 and preferably maintains an electrode 600. With additional reference to
The electrode 600 is preferably a band electrode electrically connected to one or more of the cluster of electrode wires 594. With this configuration, the electrode 600 serves as a mapping electrode. Notably, however, the electrode 600 is not a necessary element for use of the delivery catheter 552.
The intermediate region 572 is preferably formed of a material different from that of the proximal region 570. More particularly, unlike the preferably reinforced, torqueable composition of the proximal region 570, the intermediate region 572 is preferably comprised of a softer material such as nylon, polyurethane, or polyether block amide sold under the trademark PEBAX. With this configuration, the intermediate region 572 is highly amenable to bending via tensioning of the first pull wire 590. To this end, a length of the intermediate region 572 (i.e., longitudinal distance proximal the opening 560) dictates the focal point at which bending of the intermediate region 572 occurs, as well as an available bend radius. In a preferred embodiment, the intermediate region 572 has a longitudinal length in the range of 5-25 cm, more preferably 15 cm.
The opening 560 is shown more clearly in
The distal locator 556 extends distally beyond the opening 560 and preferably includes electrode pairs 610a and 610b. Further, the distal locator 556 preferably terminates at a tip 612 that, in one preferred embodiment, incorporates a thermocouple and serves as an electrode pair with an electrode 614. With additional reference to
The distal locator 556 is preferably formed from a soft material similar to the intermediate region 572, preferably nylon, polyurethane, or polyether block amide sold under the trademark PEBAX. With this configuration, the distal locator 556 is bendable or steerable via tensioning of the second pull wire 592. In a preferred embodiment, the distal locator 556 has a length in the range of 5-20 cm, more preferably 15 cm; and a diameter in the range of 5-7 French, more preferably 6 French.
Returning to
To facilitate deployment of the ablation catheter 554, a distal end 624 of the distal portion 620 extends radially outwardly relative to a curvature defined by the ablation section 622. This relationship is shown most clearly in
Returning to
The delivery catheter 552 can further include an additional anchoring device (not shown), such as the balloon 136 (
During use, the delivery catheter 552 is first directed toward the target site (e.g., pulmonary vein ostium). In one preferred embodiment, prior to placement in the patient, the ablation catheter 554 is replaced with a rounded-tip dilator (not shown) known in the art that extends through the delivery lumen 558 and partially out of the opening 560. By providing the dilator, the delivery catheter 552 can be fed through bodily lumens, such as veins, without damaging the tissue walls at the opening 560. Once the intermediate region 572 and the distal locator 556 of the delivery catheter 552 have been guided to the general area of interest (e.g., the left atrium LA), the rounded-tip dilator is removed from the delivery lumen 558, and the ablation catheter 554 inserted therein. The distal portion 620 of the ablation catheter 554 is then deployed through the opening 560. In particular, as the distal portion 620 is directed distally through the opening 560, the ablation catheter 554 is rotated such that the distal end 624 passes around the distal locator 556. The preferred deflected or tangential orientation of the distal end 624 relative to a curvature of a remainder of the distal portion 620 facilitates guiding of the distal end 624 around the distal locator 556. Continued rotation of the ablation catheter 554 positions the distal locator 556 within the circle or spiral defined by the distal portion 620.
With the ablation catheter 554 deployed to the position depicted in
Once the distal locator 556 has been positioned within the ostium in question, the ablation catheter 554 is advanced, with the distal locator 556 effectively “guiding” the distal portion 620, and in particular the ablation section 622, to the target site. In other words, the distal portion 620 “rides” along the distal locator 556 and is thereby properly positioned about the pulmonary vein ostium. Once positioned, the ablation catheter 554 is available to form a continuous ablation pattern on the chamber wall outside of/around the pulmonary vein ostium as previously described. If other of the pulmonary vein ostia require electrical isolation, the distal locator 556 can readily be aligned with the desired ostium by steering or bending of the delivery catheter 552 both proximal and distal the opening 560 as previously described.
Yet another alternative, even more preferred, embodiment of a catheter assembly 700 is shown in
The input components can assume a wide variety of forms relating to desired functioning of the catheter assembly 700. For example, in one preferred embodiment, the input components 702 include a hand piece 708, a fluid input port 710 and an ablative energy source 712 (only a portion of which is depicted in
Alternatively, and as described below, where the catheter assembly 700 is designed to make use of a differing ablation energy technique, one or both of the fluid input port 710 and/or the electrical connector 712 can be eliminated, modified or replaced with an appropriate component. For example, the catheter assembly 700 can be configured to ablate tissue via energized band or coil electrodes, ultrasound, RF energy, microwave energy, laser, cryogenic energy, thermal energy, etc., as is known in the art.
The catheter body 704 includes a proximal portion 716, an intermediate portion 718 and a distal portion 720. As with previous embodiments, the intermediate portion 718 extends from the proximal portion 716 and defines a longitudinal axis. The distal portion 720, in turn, extends from the intermediate portion 718, and includes an ablation section 722 and a tip 724. The tip 724 extends distally from the ablation section 722, and, in one preferred embodiment, terminates in a leader section 726.
The shape of the distal portion 720 is an important feature of the catheter body 704. In particular, at least a segment of the distal portion 720 defines a distally decreasing radius helix. In this regard, the ablation section 722 generally forms at least one loop that is preferably transverse to the longitudinal axis defined by the intermediate portion 718. With the one preferred embodiment of
The tip 724 includes a proximal section 728 that continues the distally decreasing radius helix otherwise defined by the ablation section 722. That is to say, a relatively uniform decreasing radius helix is defined by the ablation section 722 and the proximal section 728 of the tip 724. However, the proximal section 728 of the tip 724 is preferably not capable of ablating tissue during an ablative procedure at the ablation section 722, as described below. The proximal section 728 of
Finally, the leader section 726 extends distally from the proximal section 728 and is preferably relatively linear. To this end, the leader section 726 can be coaxially aligned with, or angled with respect to, a central axis defined by the intermediate portion 718. Stated otherwise, the relatively linear leader section 726 is preferably angled with respect to, alternatively aligned with, a central axis defined by the helix of the ablation section 722/proximal section 728. Regardless, by employing a relatively linear or straight design, the leader section 726 more readily locates a pulmonary vein, and is easily maneuvered within a pulmonary vein. Further, the relatively linear design is easily identified on an appropriate viewing device, such as a fluoroscope, such that the leader section 726 serves as an indicator of venous branching.
In addition to the varying shapes defined by the ablation section 722 and the tip 724, other differing features are preferably provided. For example, in a most preferred embodiment, the catheter body 704 is highly similar to the catheter body 402 (
An additional preferred feature of the catheter assembly 700 is the inclusion of an electrode 729 on the leader section 726; spaced electrodes 730 (referenced generally in
In a most preferred embodiment, the electrodes 730 along the proximal section 728 of the tip 724 are located at specific radial locations of the formed helix. The location of each of the electrodes 730 correlates with a radial location of respective ones of the preferred coil electrodes (not shown) relative to the helix of the ablation section 722. This relationship is best illustrated by the diagrammatic view of
Returning to
Use of the catheter assembly 700 is highly similar to that previously described with respect to
PV. Once the pulmonary vein has been located, the distal portion 720 is advanced until the ablation section 722 contacts the tissue wall W about the pulmonary vein ostium PVO. In this regard, the tip 724 readily slides along and within the pulmonary vein PV. The tip 724 is preferably formed of an atraumatic material such that contact between the tip 724 and the pulmonary vein PV does not damage the pulmonary vein PV tissue. Further, the preferred distally decreasing radius helix formed by the proximal section 728 of the tip 724 contacts the pulmonary vein PV wall, effectively seating the distal portion 720 within the pulmonary vein PV. Once seated, the ablation section 722 is essentially centered about the pulmonary vein ostium PVO. Subsequently, as the ablation section 722 is compressed (not illustrated in
Once properly positioned, extra-ostial ablation via the ablation section 722 is initiated. For example, with the one most preferred embodiment and as previously described, an appropriate fluid is irrigated through the ablation section 722, and is then energized via the coil electrode(s) (not shown), for example with RF energy. This energy is transferred, via the fluid irrigated along the ablation section 722, to the tissue contacted by the ablation section 722. The conductive fluid establishes a conductive path from the coil electrode(s) to the contacted tissue, thereby ablating the targeted tissue. Depending upon operator preference and indications of electrical activity recorded from the electrodes 730, it is possible to selectively ablate only specific portions of the extra-ostial perimeter by applying energy only to specific ones of the coil electrodes. In some instances, the atrial tissue fibers extend into the pulmonary vein PV along only a portion of the pulmonary vein ostium PVO circumference. The operator may desire to only ablate at this specific location, as opposed to forming a complete, closed ablation pattern. The catheter assembly 700 of the present invention promotes this procedure. In particular, and with additional reference to
Following application of the ablation energy, the catheter assembly 700 is preferably operated to determine whether a closed, electrically isolating ablation pattern has been established in the chamber wall W, about or outside of the pulmonary vein ostium PVO. More particularly, one or more of the electrodes 729, 730, 732, and 734 are interrogated to evaluate electrical isolation of the pulmonary vein PV from the atrium wall W. The electrodes 729 along the tip 724 provide information relating electrical activity within the pulmonary vein PV, whereas the electrodes 732, 734 provide information relating to electrical activity within the left atrium LA. Thus, where the electrodes 729, 730, 732 and 734 are ECG reference electrodes, a comparison can be made between the electrical activity within the pulmonary vein PV (via the electrodes 730) and the electrical activity with the left atrium LA (via the electrodes 732, 734) or electrical activity sensed from a catheter placed in the coronary sinus. If it is determined that electrical activity within the pulmonary vein PV is similar or otherwise related to electrical activity at the left atrium LA, further ablation of the tissue wall W is required. Ablation energy can again be applied to further ablate the tissue wall W about the pulmonary vein ostium PVO. Once sufficient ablation has been achieved, the distal section 720 is retracted from the pulmonary vein PV. Subsequently, additional ablation patterns can be formed about other ones or all of the pulmonary vein ostia PVOs.
To best illustrate the ablation pattern capabilities of the catheter assembly 700, reference is made to the diagrammatic ablation illustrations of
As previously described, the catheter assembly 700 can assume a wide variety of forms beyond the specific embodiment of
Yet another alternative embodiment catheter assembly 740 is shown in
The ablation section 750 forms a loop substantially transverse to the longitudinal axis. In the embodiment of
As with the catheter assembly 700 (
In a preferred embodiment, a shaping wire 760 (shown partially in
During use, and with reference to
Once properly positioned, an ablative energy is applied to the tissue wall W via the ablation section 750. Following application of the ablation energy, the electrodes 754, 756 and 758 are operated to sense electrical activity inside and outside of the pulmonary vein, as previously described. If it is determined that electrical activity continues to traverse the ablated lesion or selected portion(s) of the circumference, an ablation energy can again be applied to further ablate the tissue wall W about the entire pulmonary vein ostium PVO or only about selected portions of the pulmonary vein ostium as previously described.
Yet another alternative embodiment catheter assembly 770 is depicted in
The tip 782 extends distally from the ablation section 780. Further, the ablation section 780 and the tip 782 combine to define a distally decreasing radius helix for the distal portion 778. Thus, unlike the catheter bodies 704, 742 previously described, the ablation section 780 and the tip 782 define a continuous shape. However, the ablation section 780 and the tip 782 have other varying features. For example, in the preferred embodiment, the ablation section 780 is formed of a microporous material, preferably expanded PTFE, previously described; whereas the tip 782 is formed of a fluid impermeable material. Further, the tip 782 is formed of an atraumatic material such as low durometer elastromer or thermoplastic and/or utilizing a smaller diameter shaping wire 784, and is thus softer than the ablation section 780.
As with previous embodiments, the catheter assembly 770 preferably incorporates a shaping wire 784 to selectively dictate the distally decreasing helical shape of the distal section 778. Once again, the shaping wire 784 preferably carries one or more coil electrodes (not shown) positioned within the ablation section 780. The coil electrodes serve to energize, via an ablative energy source (not shown), fluid irrigated through the ablation section 780. Alternatively, the distally decreasing helical shape of the distal portion 778 can be achieved with something other than the shaping wire 784, for example thermally formed thermoplastics or mechanically manipulated torque and puller wires that create a helical shape. Further, an ablation technique other than energized conductive fluid irrigated through the ablation section 780 can be incorporated into the catheter body 772. Regardless, the catheter body 772 preferably carries an electrode 786 along the tip 782 and an electrode 788 along the intermediate portion 776.
During use, the distal portion 778 is deployed similar to the embodiments previously described with respect to
The catheter assembly of the present invention provides a highly viable tool for electrically isolating a vessel, such as a pulmonary vein or coronary sinus, from a chamber, such as the left atrium. With respect to one preferred embodiment in which the distal portion of the catheter body forms a distally decreasing radius helix, the ablation section is readily and consistently positioned about a pulmonary vein ostium. In this regard, by forming the distal portion to include both an ablation section and a distally extending tip, the pulmonary vein in question is easily located. Further, the tip is preferably formed to seat within the pulmonary vein, thereby providing a user with a tactile confirmation of proper positioning. Finally, reference electrodes are preferably provided both inside and outside of the pulmonary vein to confirm electrical isolation thereof following ablation.
Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. For example, the preferred embodiment has described electrical isolation of a pulmonary vein from the left atrium for treatment of atrial fibrillation. Alternatively, the method and apparatus of the present invention may be utilized in the treatment of other cardiac arrhythmias, such as isolating the coronary sinus from the right atrium, the superior vena cava, or isolating the outflow tract (or pulmonary valve) from the right ventricle. Further, with respect to the preferred embodiments described with reference to
Claims
1. A catheter assembly, comprising:
- an elongated body having a proximal region and a distal region extending along a longitudinal axis, wherein the distal region of the body is configured for intravascular delivery to a body lumen of a human patient;
- a pre-shaped spiral structure associated with the distal region of the elongated body, wherein the spiral structure is transformable between a low-profile configuration and an expanded configuration; and
- a plurality of electrodes spaced apart along the spiral structure, wherein each of the electrodes comprises a wire wound about a corresponding length of the spiral structure,
- wherein, when the spiral structure is in the expanded configuration, the spiral structure comprises a plurality of loops longitudinally spaced apart from each other and extending lengthwise along a central loop axis parallel with the longitudinal axis of the elongated body, and
- wherein the electrodes are disposed along the loops and configured to apply energy in a lesion pattern along a length of the body lumen of the human patient.
2. The catheter assembly of claim 1 wherein the plurality of electrodes includes a first electrode and a second electrode, and wherein the first electrode and the second electrode are electrically isolated from one another.
3. The catheter assembly of claim 1 wherein the plurality of electrodes includes a first electrode and a second electrode, and wherein, in the expanded configuration, the spiral structure includes a first revolution, and further wherein:
- the first electrode extends a first length along the longitudinal axis of the spiral structure; and
- the second electrode extends a second length along the longitudinal axis of the spiral structure,
- wherein the first length and the second length combined are greater than a length of the first revolution of the spiral structure.
4. The catheter assembly of claim 1 wherein the plurality of electrodes includes a first electrode and a second electrode and wherein, in the expanded configuration, the spiral structure includes a first revolution, and further wherein:
- the first electrode extends a first length along the longitudinal axis of the spiral structure; and
- the second electrode extends a second length along the longitudinal axis of the spiral structure, and
- wherein each of the first length and the second length are less than a length of the first revolution of the spiral structure.
5. The catheter assembly of claim 1 wherein the plurality of electrodes includes a first electrode and a second electrode, and wherein:
- the first electrode extends a first length along the longitudinal axis of the spiral structure; and
- the second electrode extends a second length along the longitudinal axis of the spiral structure, and
- wherein the first length is different than the second length.
6. The catheter assembly of claim 1 wherein the plurality of electrodes includes a first electrode and a second electrode, and wherein:
- the first electrode extends a first length along the longitudinal axis of the spiral structure; and
- the second electrode extends a second length along the longitudinal axis of the spiral structure, and
- wherein the first length is the same as the second length.
7. The catheter assembly of claim 1 wherein the elongated body and the spiral structure include a lumen therethrough, and wherein:
- in the low-profile configuration, a stylet or guide wire is positioned in the lumen of the spiral structure; and
- in the expanded configuration, the stylet or guide wire is at least partially retracted from the spiral structure toward the proximal region of the elongated body.
8. A catheter assembly, comprising:
- an elongated body having a proximal region, a distal region extending along a longitudinal axis, and a lumen therethrough, wherein the distal region of the body is configured for intravascular delivery to a blood vessel of a human patient;
- a pre-shaped spiral structure at the distal region of the elongated body, wherein the spiral structure includes a lumen therethrough, wherein the spiral structure is selectively transformable between— a delivery state wherein a stylet or guide wire is positioned in the lumen of the spiral structure; and an expanded state wherein the stylet or guide wire is at least partially retracted from the spiral structure toward the proximal region of the elongated body; and
- a plurality of energy delivery elements spaced apart along the spiral structure, wherein each energy delivery element comprises a flexible coil wound about a corresponding length of the spiral structure,
- wherein the spiral structure, in the expanded state, comprises a plurality of loops spaced longitudinally apart from each other and extending lengthwise along a central loop axis generally parallel with the longitudinal axis of the elongated body, and
- wherein the electrodes are disposed along the loops and configured to apply energy in a lesion pattern along a length of the blood vessel of the human patient.
9. The catheter assembly of claim 8 wherein each flexible coil is comprised of a wire.
10. The catheter assembly of claim 9 wherein at least one of the wires is composed of platinum.
11. The catheter assembly of claim 9 wherein at least one of the wires is composed of copper.
12. The catheter assembly of claim 8 wherein the spiral structure is composed of a shape memory material that biases the spiral structure to the expanded state.
13. The catheter assembly of claim 8 wherein the energy delivery elements are arranged on the spiral structure to form the lesion pattern of discrete, non-continuous lesions at a target treatment site within the blood vessel when the spiral structure is in the expanded state.
14. The catheter assembly of claim 8, further comprising a retractable sheath at least partially surrounding the distal region of the elongated body when the spiral structure is in the delivery state.
15. The catheter assembly of claim 8 wherein the elongated body is configured for over-the-wire or rapid exchange delivery techniques.
16. The catheter assembly of claim 8 wherein the spiral structure comprises a generally uniform diameter in the expanded state.
17. The catheter assembly of claim 8 wherein the plurality of energy delivery elements includes a first flexible coil electrode and a second flexible coil electrode, and wherein the first electrode and the second electrode are electrically isolated from one another.
18. The catheter assembly of claim 8 wherein the plurality of energy delivery elements includes a first energy delivery element and a second energy delivery element, and wherein, in the expanded state, the spiral structure includes a first revolution, and further wherein:
- the first energy delivery element extends a first length along the longitudinal axis of the spiral structure; and
- the second energy delivery element extends a second length along the longitudinal axis of the spiral structure, and
- wherein the first length and the second length combined are greater than a length of the first revolution of the spiral structure.
19. The catheter assembly of claim 8 wherein the plurality of energy delivery elements includes a first energy delivery element and a second energy delivery element, and wherein, in the expanded state, the spiral structure includes a first revolution, and further wherein:
- the first energy delivery element extends a first length along the longitudinal axis of the spiral structure; and
- the second energy delivery element extends a second length along the longitudinal axis of the spiral structure, and
- wherein each of the first length and the second length are less than a length of the first revolution of the spiral structure.
20. The catheter assembly of claim 8 wherein the plurality of energy delivery elements includes a first energy delivery element and a second energy delivery element, and wherein:
- the first energy delivery element extends a first length along the longitudinal axis of the spiral structure; and
- the second energy delivery element extends a second length along the longitudinal axis of the spiral structure,
- wherein the first length is different than the second length.
21. The catheter assembly of claim 8 wherein the plurality of energy delivery elements includes a first energy delivery element and a second energy delivery element, and wherein:
- the first energy delivery element extends a first length along the longitudinal axis of the spiral structure; and
- the second energy delivery element extends a second length along the longitudinal axis of the spiral structure, and
- wherein the first length is the same as the second length.
3935348 | January 27, 1976 | Smith |
4154246 | May 15, 1979 | LeVeen |
4169464 | October 2, 1979 | Obrez |
4419819 | December 13, 1983 | Dickhudt et al. |
4660571 | April 28, 1987 | Hess et al. |
4706671 | November 17, 1987 | Weinrib |
4709698 | December 1, 1987 | Johnston et al. |
4781682 | November 1, 1988 | Patel |
4796643 | January 10, 1989 | Nakazawa et al. |
4819661 | April 11, 1989 | Heil, Jr. et al. |
4834724 | May 30, 1989 | Geiss et al. |
4860769 | August 29, 1989 | Fogarty et al. |
4920979 | May 1, 1990 | Bullara |
4921484 | May 1, 1990 | Hillstead |
4957118 | September 18, 1990 | Erlebacher |
4961377 | October 9, 1990 | Bando et al. |
4995868 | February 26, 1991 | Brazier |
5002067 | March 26, 1991 | Berthelsen et al. |
5011488 | April 30, 1991 | Ginsburg |
5016808 | May 21, 1991 | Heil, Jr. et al. |
5052998 | October 1, 1991 | Zimmon |
5054501 | October 8, 1991 | Chuttani et al. |
5071407 | December 10, 1991 | Termin et al. |
5071424 | December 10, 1991 | Reger |
5133365 | July 28, 1992 | Heil, Jr. et al. |
5156151 | October 20, 1992 | Imran |
5156610 | October 20, 1992 | Reger |
5158564 | October 27, 1992 | Schnepp-Pesch et al. |
5163928 | November 17, 1992 | Hobbs et al. |
5188602 | February 23, 1993 | Nichols |
5188619 | February 23, 1993 | Myers |
5209723 | May 11, 1993 | Twardowski et al. |
5211651 | May 18, 1993 | Reger et al. |
5228442 | July 20, 1993 | Imran |
5239999 | August 31, 1993 | Imran |
5249585 | October 5, 1993 | Turner et al. |
5263492 | November 23, 1993 | Voyce |
5263493 | November 23, 1993 | Avitall |
5279299 | January 18, 1994 | Imran |
5282484 | February 1, 1994 | Reger |
5296510 | March 22, 1994 | Yamada et al. |
5300099 | April 5, 1994 | Rudie |
5308323 | May 3, 1994 | Sogawa et al. |
5318525 | June 7, 1994 | West et al. |
5324284 | June 28, 1994 | Imran |
5327905 | July 12, 1994 | Avitall |
5345031 | September 6, 1994 | Schwartz et al. |
5345936 | September 13, 1994 | Pomeranz et al. |
5354297 | October 11, 1994 | Avitall |
5365926 | November 22, 1994 | Desai |
5383856 | January 24, 1995 | Bersin |
5387233 | February 7, 1995 | Alferness et al. |
5397304 | March 14, 1995 | Truckai |
5397339 | March 14, 1995 | Desai |
5405374 | April 11, 1995 | Stein |
5411546 | May 2, 1995 | Bowald et al. |
5425364 | June 20, 1995 | Imran |
5427118 | June 27, 1995 | Nita et al. |
5462545 | October 31, 1995 | Wang |
5462546 | October 31, 1995 | Rydell |
5476495 | December 19, 1995 | Kordis et al. |
5476498 | December 19, 1995 | Ayers |
5487385 | January 30, 1996 | Avitall |
5487757 | January 30, 1996 | Truckai et al. |
5497774 | March 12, 1996 | Swartz et al. |
5505201 | April 9, 1996 | Grill, Jr. et al. |
5507743 | April 16, 1996 | Edwards et al. |
5509909 | April 23, 1996 | Moy |
5523092 | June 4, 1996 | Hanson et al. |
5529820 | June 25, 1996 | Nomi et al. |
5545193 | August 13, 1996 | Fleischman et al. |
5545200 | August 13, 1996 | West et al. |
5545475 | August 13, 1996 | Korleski |
5549661 | August 27, 1996 | Kordis et al. |
5564440 | October 15, 1996 | Swartz et al. |
5575766 | November 19, 1996 | Swartz et al. |
5575810 | November 19, 1996 | Swanson et al. |
5582609 | December 10, 1996 | Swanson |
5591132 | January 7, 1997 | Carrie |
5609151 | March 11, 1997 | Mulier et al. |
5617854 | April 8, 1997 | Munsif |
5628775 | May 13, 1997 | Jackson et al. |
5636634 | June 10, 1997 | Kordis et al. |
5637090 | June 10, 1997 | McGee et al. |
5642736 | July 1, 1997 | Avitall |
5676662 | October 14, 1997 | Fleischhacker et al. |
5678296 | October 21, 1997 | Fleischhacker et al. |
5680860 | October 28, 1997 | Imran |
5681280 | October 28, 1997 | Rusk et al. |
5687723 | November 18, 1997 | Avitall |
5690611 | November 25, 1997 | Swartz et al. |
5693082 | December 2, 1997 | Warner et al. |
5697928 | December 16, 1997 | Walcott et al. |
5709874 | January 20, 1998 | Hanson et al. |
5715818 | February 10, 1998 | Swartz et al. |
5716410 | February 10, 1998 | Wang et al. |
5722401 | March 3, 1998 | Pietroski et al. |
5725512 | March 10, 1998 | Swartz et al. |
5727555 | March 17, 1998 | Chait |
5730127 | March 24, 1998 | Avitall |
5730741 | March 24, 1998 | Horzewski et al. |
5755760 | May 26, 1998 | Maguire et al. |
5755761 | May 26, 1998 | Obino |
5772590 | June 30, 1998 | Webster, Jr. |
5800494 | September 1, 1998 | Campbell et al. |
5807395 | September 15, 1998 | Mulier et al. |
5810802 | September 22, 1998 | Panescu |
5814028 | September 29, 1998 | Swartz et al. |
5823955 | October 20, 1998 | Kuck |
5827242 | October 27, 1998 | Follmer et al. |
5827268 | October 27, 1998 | Laufer |
5842984 | December 1, 1998 | Avitall |
5846355 | December 8, 1998 | Spencer et al. |
5860920 | January 19, 1999 | McGee et al. |
5860974 | January 19, 1999 | Abele |
5865815 | February 2, 1999 | Tihon |
5871523 | February 16, 1999 | Fleischman et al. |
5871531 | February 16, 1999 | Struble |
5873865 | February 23, 1999 | Horzewski et al. |
5879295 | March 9, 1999 | Li et al. |
5882333 | March 16, 1999 | Schaer et al. |
5882346 | March 16, 1999 | Pomeranz |
5891114 | April 6, 1999 | Chien et al. |
5910129 | June 8, 1999 | Koblish et al. |
5931848 | August 3, 1999 | Saadat |
5938694 | August 17, 1999 | Jaraczewski et al. |
5941823 | August 24, 1999 | Chait |
5944710 | August 31, 1999 | Dev et al. |
5951471 | September 14, 1999 | de la Rama et al. |
5951494 | September 14, 1999 | Wang et al. |
5951539 | September 14, 1999 | Nita et al. |
5957961 | September 28, 1999 | Maguire et al. |
5968085 | October 19, 1999 | Morris et al. |
5972019 | October 26, 1999 | Engelson et al. |
5972026 | October 26, 1999 | Laufer et al. |
5980516 | November 9, 1999 | Mulier et al. |
5993462 | November 30, 1999 | Pomeranz et al. |
5997526 | December 7, 1999 | Giba |
6004269 | December 21, 1999 | Crowley et al. |
6004316 | December 21, 1999 | Laufer |
6004348 | December 21, 1999 | Banas et al. |
6012457 | January 11, 2000 | Lesh |
6032077 | February 29, 2000 | Pomeranz |
6042578 | March 28, 2000 | Dinh et al. |
6048329 | April 11, 2000 | Thompson et al. |
6064902 | May 16, 2000 | Haissaguerre et al. |
6071729 | June 6, 2000 | Jeffries et al. |
6074339 | June 13, 2000 | Gambale et al. |
6074361 | June 13, 2000 | Jacobs |
6074378 | June 13, 2000 | Mouri et al. |
6076012 | June 13, 2000 | Swanson et al. |
6078840 | June 20, 2000 | Stokes |
6078841 | June 20, 2000 | Kuzma |
6090104 | July 18, 2000 | Webster, Jr. |
6094596 | July 25, 2000 | Morgan |
6096036 | August 1, 2000 | Bowe et al. |
6106522 | August 22, 2000 | Fleischman |
6125302 | September 26, 2000 | Kuzma |
6129724 | October 10, 2000 | Fleischman |
6129750 | October 10, 2000 | Tockman et al. |
6132456 | October 17, 2000 | Sommer et al. |
6146381 | November 14, 2000 | Bowe et al. |
6152912 | November 28, 2000 | Jansen et al. |
6156046 | December 5, 2000 | Passafaro et al. |
6161049 | December 12, 2000 | Rudie et al. |
6164283 | December 26, 2000 | Lesh |
6190356 | February 20, 2001 | Bersin |
6214002 | April 10, 2001 | Fleischman et al. |
6219577 | April 17, 2001 | Brown, III et al. |
6223070 | April 24, 2001 | Chait |
6228109 | May 8, 2001 | Tu et al. |
6270496 | August 7, 2001 | Bowe et al. |
6280441 | August 28, 2001 | Ryan |
6292695 | September 18, 2001 | Webster, Jr. et al. |
6308090 | October 23, 2001 | Tu et al. |
6322559 | November 27, 2001 | Daulton et al. |
6325797 | December 4, 2001 | Stewart et al. |
6364904 | April 2, 2002 | Smith |
6385472 | May 7, 2002 | Hall et al. |
6405732 | June 18, 2002 | Edwards et al. |
6409742 | June 25, 2002 | Fulton, III et al. |
6430426 | August 6, 2002 | Avitall |
6436056 | August 20, 2002 | Wang et al. |
6442415 | August 27, 2002 | Bis et al. |
6451045 | September 17, 2002 | Walker et al. |
6454775 | September 24, 2002 | Demarais et al. |
6480747 | November 12, 2002 | Schmidt |
6496737 | December 17, 2002 | Rudie et al. |
6500174 | December 31, 2002 | Maguire et al. |
6508804 | January 21, 2003 | Sarge et al. |
6511492 | January 28, 2003 | Rosenbluth et al. |
6514249 | February 4, 2003 | Maguire et al. |
6527739 | March 4, 2003 | Bigus et al. |
6529756 | March 4, 2003 | Phan et al. |
6530935 | March 11, 2003 | Wensel et al. |
6540734 | April 1, 2003 | Chiu et al. |
6542781 | April 1, 2003 | Koblish |
6546272 | April 8, 2003 | MacKinnon et al. |
6546280 | April 8, 2003 | Osborne |
6562031 | May 13, 2003 | Chandrasekaran et al. |
6562034 | May 13, 2003 | Edwards et al. |
6564096 | May 13, 2003 | Mest |
6572612 | June 3, 2003 | Stewart et al. |
6592581 | July 15, 2003 | Bowe |
6602242 | August 5, 2003 | Fung et al. |
6605061 | August 12, 2003 | VanTassel et al. |
6607520 | August 19, 2003 | Keane |
6610046 | August 26, 2003 | Usami et al. |
6610083 | August 26, 2003 | Keller et al. |
6613046 | September 2, 2003 | Jenkins et al. |
6616624 | September 9, 2003 | Kieval |
6622731 | September 23, 2003 | Daniel et al. |
6623515 | September 23, 2003 | Mulier et al. |
6628976 | September 30, 2003 | Fuimaono et al. |
6652517 | November 25, 2003 | Hall et al. |
6692490 | February 17, 2004 | Edwards |
6702811 | March 9, 2004 | Stewart et al. |
6711444 | March 23, 2004 | Koblish |
6745080 | June 1, 2004 | Koblish |
6746474 | June 8, 2004 | Saadat |
6758830 | July 6, 2004 | Schaer et al. |
6773433 | August 10, 2004 | Stewart et al. |
6780183 | August 24, 2004 | Jimenez, Jr. et al. |
6802840 | October 12, 2004 | Chin et al. |
6802857 | October 12, 2004 | Walsh et al. |
6814733 | November 9, 2004 | Schwartz et al. |
6817999 | November 16, 2004 | Berube et al. |
6847848 | January 25, 2005 | Sterzer et al. |
6869431 | March 22, 2005 | Maguire et al. |
6882886 | April 19, 2005 | Witte et al. |
6890329 | May 10, 2005 | Carroll et al. |
6893438 | May 17, 2005 | Hall et al. |
6899711 | May 31, 2005 | Stewart et al. |
6905510 | June 14, 2005 | Saab |
6909920 | June 21, 2005 | Lokhoff et al. |
6923808 | August 2, 2005 | Taimisto |
6941953 | September 13, 2005 | Feld et al. |
6949097 | September 27, 2005 | Stewart et al. |
6952615 | October 4, 2005 | Satake |
6960206 | November 1, 2005 | Keane |
6960207 | November 1, 2005 | Vanney et al. |
6972016 | December 6, 2005 | Hill, III et al. |
7013169 | March 14, 2006 | Bowe |
7013170 | March 14, 2006 | Bowe |
7058456 | June 6, 2006 | Pierce |
7063719 | June 20, 2006 | Jansen et al. |
7081115 | July 25, 2006 | Taimisto |
7104988 | September 12, 2006 | Altman et al. |
7110828 | September 19, 2006 | Kolberg et al. |
7115134 | October 3, 2006 | Chambers |
7155271 | December 26, 2006 | Halperin et al. |
7158832 | January 2, 2007 | Kieval et al. |
7184811 | February 27, 2007 | Phan et al. |
7201738 | April 10, 2007 | Bengmark |
7211082 | May 1, 2007 | Hall et al |
7232458 | June 19, 2007 | Saadat |
7254451 | August 7, 2007 | Seifert et al. |
7264619 | September 4, 2007 | Venturelli |
7282213 | October 16, 2007 | Schroeder et al. |
7285119 | October 23, 2007 | Stewart et al. |
7291146 | November 6, 2007 | Steinke et al. |
7311705 | December 25, 2007 | Sra |
7404824 | July 29, 2008 | Webler et al. |
7435248 | October 14, 2008 | Taimisto et al. |
7517349 | April 14, 2009 | Truckai et al. |
7526343 | April 28, 2009 | Peterson et al. |
7542808 | June 2, 2009 | Peterson et al. |
7597704 | October 6, 2009 | Frazier et al. |
7637903 | December 29, 2009 | Lentz |
7646544 | January 12, 2010 | Batchko et al. |
7647124 | January 12, 2010 | Williams |
7653438 | January 26, 2010 | Deem et al. |
7670335 | March 2, 2010 | Keidar |
7682319 | March 23, 2010 | Martin et al. |
7717853 | May 18, 2010 | Nita |
7727178 | June 1, 2010 | Wilson et al. |
7729782 | June 1, 2010 | Williams et al. |
7747334 | June 29, 2010 | Bly et al. |
7771421 | August 10, 2010 | Stewart et al. |
7789877 | September 7, 2010 | Vanney |
7806871 | October 5, 2010 | Li et al. |
7850685 | December 14, 2010 | Kunis et al. |
7863897 | January 4, 2011 | Slocum, Jr. et al. |
7867219 | January 11, 2011 | Chambers |
7881807 | February 1, 2011 | Schaer |
7890188 | February 15, 2011 | Zhang et al. |
7927370 | April 19, 2011 | Webler et al. |
7937160 | May 3, 2011 | Garabedian |
7942928 | May 17, 2011 | Webler et al. |
7959630 | June 14, 2011 | Taimisto et al. |
8019435 | September 13, 2011 | Hastings et al. |
8062284 | November 22, 2011 | Booth |
8100859 | January 24, 2012 | Patterson et al. |
8123739 | February 28, 2012 | McQueen et al. |
8192428 | June 5, 2012 | Truckai et al. |
8257351 | September 4, 2012 | Stewart et al. |
8308722 | November 13, 2012 | Ormsby et al. |
8337492 | December 25, 2012 | Kunis et al. |
8380275 | February 19, 2013 | Kim et al. |
8398629 | March 19, 2013 | Thistle |
8480663 | July 9, 2013 | Ingle et al. |
8571665 | October 29, 2013 | Moffitt et al. |
9014821 | April 21, 2015 | Wang |
9055956 | June 16, 2015 | McRae et al. |
20010005785 | June 28, 2001 | Sachse |
20010007070 | July 5, 2001 | Stewart et al. |
20010020174 | September 6, 2001 | Koblish |
20010031971 | October 18, 2001 | Dretler et al. |
20020004631 | January 10, 2002 | Jenkins |
20020004644 | January 10, 2002 | Koblish |
20020062124 | May 23, 2002 | Keane |
20020087208 | July 4, 2002 | Koblish et al. |
20020139379 | October 3, 2002 | Edwards et al. |
20020165532 | November 7, 2002 | Hill, III |
20020169444 | November 14, 2002 | Mest et al. |
20020177765 | November 28, 2002 | Bowe |
20020183682 | December 5, 2002 | Darvish et al. |
20030060857 | March 27, 2003 | Perrson et al. |
20030065317 | April 3, 2003 | Rudie et al. |
20030074039 | April 17, 2003 | Puskas |
20030088244 | May 8, 2003 | Swanson et al. |
20030153967 | August 14, 2003 | Koblish et al. |
20030158584 | August 21, 2003 | Cates et al. |
20030195507 | October 16, 2003 | Stewart et al. |
20030204187 | October 30, 2003 | Hintringer et al. |
20030216792 | November 20, 2003 | Levin et al. |
20030233099 | December 18, 2003 | Danaek et al. |
20040024371 | February 5, 2004 | Plicchi et al. |
20040030375 | February 12, 2004 | Pierce |
20040049181 | March 11, 2004 | Stewart et al. |
20040082978 | April 29, 2004 | Harrison et al. |
20040122421 | June 24, 2004 | Wood |
20040167509 | August 26, 2004 | Taimisto |
20050010095 | January 13, 2005 | Stewart et al. |
20050033137 | February 10, 2005 | Oral |
20050070887 | March 31, 2005 | Taimisto |
20060025762 | February 2, 2006 | Mohan |
20060074403 | April 6, 2006 | Rafiee |
20060100618 | May 11, 2006 | Chan et al. |
20060135870 | June 22, 2006 | Webler |
20060135953 | June 22, 2006 | Kania et al. |
20060241366 | October 26, 2006 | Falwell |
20060247618 | November 2, 2006 | Kaplan et al. |
20060247619 | November 2, 2006 | Kaplan et al. |
20070043409 | February 22, 2007 | Brian et al. |
20070083194 | April 12, 2007 | Kunis et al. |
20070225781 | September 27, 2007 | Saadat et al. |
20080021408 | January 24, 2008 | Jacobsen et al. |
20080045921 | February 21, 2008 | Anderson et al. |
20080064957 | March 13, 2008 | Spence |
20080097398 | April 24, 2008 | Mitelberg et al. |
20080108975 | May 8, 2008 | Appling et al. |
20080109011 | May 8, 2008 | Thenuwara et al. |
20080172104 | July 17, 2008 | Kieval et al. |
20080183187 | July 31, 2008 | Bly |
20080255539 | October 16, 2008 | Booth |
20080288039 | November 20, 2008 | Reddy |
20080300587 | December 4, 2008 | Anderson |
20090018534 | January 15, 2009 | Taimisto et al. |
20090287202 | November 19, 2009 | Ingle et al. |
20090306650 | December 10, 2009 | Govari et al. |
20090312606 | December 17, 2009 | Dayton et al. |
20100030112 | February 4, 2010 | Anderson et al. |
20100168777 | July 1, 2010 | Stangenes et al. |
20100174282 | July 8, 2010 | Demarais et al. |
20100179512 | July 15, 2010 | Chong et al. |
20100204692 | August 12, 2010 | Stewart et al. |
20100261990 | October 14, 2010 | Gillis et al. |
20110021976 | January 27, 2011 | Li et al. |
20110144639 | June 16, 2011 | Govari |
20110160719 | June 30, 2011 | Govari et al. |
20110264086 | October 27, 2011 | Ingle |
20110306851 | December 15, 2011 | Wang |
20110319908 | December 29, 2011 | Thenuwara et al. |
20120010607 | January 12, 2012 | Malecki et al. |
20120029509 | February 2, 2012 | Smith |
20120029510 | February 2, 2012 | Haverkost |
20120029513 | February 2, 2012 | Smith et al. |
20120035615 | February 9, 2012 | Koester et al. |
20120078076 | March 29, 2012 | Stewart et al. |
20120101553 | April 26, 2012 | Reddy |
20120116382 | May 10, 2012 | Ku et al. |
20120116383 | May 10, 2012 | Mauch et al. |
20120116438 | May 10, 2012 | Salahieh et al. |
20120123406 | May 17, 2012 | Edmunds et al. |
20120130368 | May 24, 2012 | Jenson |
20120143293 | June 7, 2012 | Mauch et al. |
20120191083 | July 26, 2012 | Moll et al. |
20120197246 | August 2, 2012 | Mauch |
20120277842 | November 1, 2012 | Kunis |
20120290053 | November 15, 2012 | Zhang et al. |
20120310065 | December 6, 2012 | Falwell et al. |
20120310239 | December 6, 2012 | Stewart et al. |
20120323233 | December 20, 2012 | Maguire et al. |
20130053876 | February 28, 2013 | Ogle |
20130066316 | March 14, 2013 | Steinke et al. |
20130085360 | April 4, 2013 | Grunewald |
20130090637 | April 11, 2013 | Sliwa |
20130109987 | May 2, 2013 | Kunis |
20130165920 | June 27, 2013 | Weber et al. |
20130165921 | June 27, 2013 | Sutermeister et al. |
20130172872 | July 4, 2013 | Subramaniam et al. |
20130172879 | July 4, 2013 | Sutermeister et al. |
20130184703 | July 18, 2013 | Shireman et al. |
20130184773 | July 18, 2013 | Libbus et al. |
20130253628 | September 26, 2013 | Smith et al. |
20130274614 | October 17, 2013 | Shimada et al. |
20130274730 | October 17, 2013 | Anderson et al. |
20130274731 | October 17, 2013 | Anderson et al. |
20130274737 | October 17, 2013 | Wang et al. |
20130282000 | October 24, 2013 | Parsonage |
20130282084 | October 24, 2013 | Mathur et al. |
20130289686 | October 31, 2013 | Masson et al. |
20130304047 | November 14, 2013 | Grunewald et al. |
20130304052 | November 14, 2013 | Rizq et al. |
20130304062 | November 14, 2013 | Chan et al. |
20140058376 | February 27, 2014 | Horn et al. |
20140213873 | July 31, 2014 | Wang |
20140214018 | July 31, 2014 | Behar et al. |
20140221805 | August 7, 2014 | Wang |
20140243821 | August 28, 2014 | Salahieh et al. |
20140249524 | September 4, 2014 | Kocur |
20140257280 | September 11, 2014 | Hanson et al. |
20140257281 | September 11, 2014 | Squire et al. |
20140276747 | September 18, 2014 | Abunassar et al. |
20140276752 | September 18, 2014 | Wang et al. |
20140276787 | September 18, 2014 | Wang et al. |
20140276789 | September 18, 2014 | Dandler et al. |
20140303617 | October 9, 2014 | Shimada |
20140350553 | November 27, 2014 | Okuyama |
20150057655 | February 26, 2015 | Osypka |
20150112329 | April 23, 2015 | Ng |
20150126992 | May 7, 2015 | Mogul |
201469401 | May 2010 | CN |
102198015 | September 2011 | CN |
102274075 | December 2011 | CN |
102488552 | June 2012 | CN |
202386778 | August 2012 | CN |
202426649 | September 2012 | CN |
202537649 | November 2012 | CN |
202538132 | November 2012 | CN |
102885648 | January 2013 | CN |
102885649 | January 2013 | CN |
102908188 | February 2013 | CN |
102908189 | February 2013 | CN |
202761434 | March 2013 | CN |
202843784 | April 2013 | CN |
102772249 | January 2015 | CN |
105167840 | December 2015 | CN |
105326562 | February 2016 | CN |
205433878 | August 2016 | CN |
205433879 | August 2016 | CN |
29909082 | July 1999 | DE |
29909082 | July 1999 | DE |
10252325 | May 2004 | DE |
10257146 | June 2004 | DE |
0132344 | January 1985 | EP |
0132344 | January 1986 | EP |
0510624 | October 1992 | EP |
510624 | July 1995 | EP |
732080 | September 1996 | EP |
0779079 | June 1997 | EP |
0821602 | February 1998 | EP |
865256 | September 1998 | EP |
868160 | October 1998 | EP |
0868923 | October 1998 | EP |
0728495 | April 1999 | EP |
0916360 | May 1999 | EP |
1042990 | October 2000 | EP |
1233716 | August 2002 | EP |
1233716 | August 2002 | EP |
1297795 | April 2003 | EP |
963191 | August 2003 | EP |
1332724 | August 2003 | EP |
757575 | September 2003 | EP |
873760 | January 2004 | EP |
1383567 | January 2004 | EP |
779079 | March 2004 | EP |
0778043 | November 2005 | EP |
1042990 | October 2006 | EP |
1733689 | December 2006 | EP |
1802370 | July 2007 | EP |
1009303 | June 2009 | EP |
2208474 | July 2010 | EP |
2263588 | December 2010 | EP |
2329859 | June 2011 | EP |
2519173 | November 2012 | EP |
2558016 | February 2013 | EP |
2570154 | March 2013 | EP |
2598069 | June 2013 | EP |
2664295 | November 2013 | EP |
2694158 | February 2014 | EP |
2759275 | July 2014 | EP |
2760532 | August 2014 | EP |
2804554 | November 2014 | EP |
355137141 | October 2008 | JP |
2015119831 | July 2015 | JP |
2016086999 | May 2016 | JP |
WO-9115254 | October 1991 | WO |
WO-9220291 | November 1992 | WO |
WO-9421168 | September 1994 | WO |
WO-9513111 | May 1995 | WO |
WO-9520416 | August 1995 | WO |
WO-9600036 | January 1996 | WO |
WO-9632980 | October 1996 | WO |
WO-9638196 | December 1996 | WO |
WO9717892 | May 1997 | WO |
WO-9717892 | May 1997 | WO |
WO-9802201 | January 1998 | WO |
WO-9818393 | May 1998 | WO |
WO-9833469 | August 1998 | WO |
WO-9843530 | October 1998 | WO |
WO-99/00060 | January 1999 | WO |
WO-9900060 | January 1999 | WO |
WO-9923958 | May 1999 | WO |
WO-9952421 | October 1999 | WO |
WO-9956801 | November 1999 | WO |
WO-9962413 | December 1999 | WO |
WO-0001313 | January 2000 | WO |
WO-0056237 | September 2000 | WO |
WO-0067832 | November 2000 | WO |
WO-0122897 | April 2001 | WO |
WO-0137723 | May 2001 | WO |
WO-0137746 | May 2001 | WO |
WO-0174255 | October 2001 | WO |
WO-0180758 | November 2001 | WO |
WO-0208301 | January 2002 | WO |
WO-0245608 | June 2002 | WO |
WO-02083017 | October 2002 | WO |
WO-02087453 | November 2002 | WO |
WO-02089687 | November 2002 | WO |
WO-02089908 | November 2002 | WO |
WO-03077781 | September 2003 | WO |
WO-03082080 | October 2003 | WO |
WO-2004100813 | November 2004 | WO |
WO-2005051216 | June 2005 | WO |
WO-2005070491 | August 2005 | WO |
WO-2006020920 | February 2006 | WO |
WO-2006065949 | June 2006 | WO |
WO-2006092000 | September 2006 | WO |
WO-2007001981 | January 2007 | WO |
WO-2007128064 | November 2007 | WO |
WO-2008101244 | August 2008 | WO |
WO-2009121017 | January 2009 | WO |
WO-2009082635 | July 2009 | WO |
WO-2010048676 | May 2010 | WO |
WO-2010091701 | August 2010 | WO |
WO-2010120835 | October 2010 | WO |
WO-2011015218 | February 2011 | WO |
WO-2011019838 | February 2011 | WO |
WO-2011/060200 | May 2011 | WO |
WO-2011055143 | May 2011 | WO |
WO-2011082279 | July 2011 | WO |
WO-2011130534 | October 2011 | WO |
WO-2012075156 | June 2012 | WO |
WO-2012130337 | October 2012 | WO |
WO-2012131107 | October 2012 | WO |
WO-2012154219 | November 2012 | WO |
WO-2012154796 | November 2012 | WO |
WO-2013016203 | January 2013 | WO |
WO-2013028993 | February 2013 | WO |
WO-2013030807 | March 2013 | WO |
WO-2013040201 | March 2013 | WO |
WO-2013049601 | April 2013 | WO |
WO-2013101452 | July 2013 | WO |
WO2013106054 | July 2013 | WO |
WO-2013109318 | July 2013 | WO |
WO2013109318 | July 2013 | WO |
WO-2013154776 | October 2013 | WO |
WO2013158676 | October 2013 | WO |
WO-2013158676 | October 2013 | WO |
WO-2013158678 | October 2013 | WO |
WO2013158678 | October 2013 | WO |
WO-2013165920 | November 2013 | WO |
WO2013165920 | November 2013 | WO |
WO2013154776 | December 2013 | WO |
WO-2014036160 | March 2014 | WO |
WO-2014036163 | March 2014 | WO |
WO-2014056460 | April 2014 | WO |
WO-2014163987 | October 2014 | WO |
WO-2014163990 | October 2014 | WO |
WO2014176785 | November 2014 | WO |
WO2016094938 | June 2016 | WO |
- European Search Report for European Application No. 13159256, Date Mailed: Oct. 17, 2013, 6 pages.
- Materials Research Society, “Biomedical Materials and Devices,” Symposium helped Nov. 30-Dec. 4, 1987, Boston Massachusetts, USA.
- Claudine Jaboro, “An in vivo study of the biocompatibility of classic and novel device materials on the central nervous system”, (Jan. 1, 2007), ETD Collection for Wayne State University. Paper AA13310737. <http://digitalcommons.wayne.edu/dissertations/AA13310737>.
- Lahiri D. et al. Boron nitride nanotube reinforced polylactide-polycaprolactone copolymer composite: Mechanical properties and cytocompatibility with osteoblasts and macrophages in vitro. Acta Biomater (2010), doi: 10.1016/j.actbio.2010.02.44.
- European Search Report dated Jan. 30, 2013; European Application No. 12180426.4; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 6 pages.
- European Search Report dated Feb. 28, 2013; European Application No. 12180427.2; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 4 pages.
- European Search Report dated Jan. 30, 2013; Application No. 12180428.0; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 6 pages.
- European Search Report dated Jan. 30, 2013; Application No. 12180430.6; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 6 pages.
- European Search Report dated Jan. 30, 2013; Application No. 12180431.4; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 6 pages.
- European Search Report dated Feb. 22, 2013; Application No. 12180432.2; Applicant: Medtronic Ardian Luxembourg S.a.r.l.; 6 pages.
- International Search Report and Written Opinion dated Jan. 23, 2012, International Application No. PCT/US2011/057761, 13 pages.
- International Search Report and Written Opinion dated Jan. 20, 2012, International Application No. PCT/US2011/057756, 10 pages.
- International Search Report and Written Opinion dated Feb. 16, 2012, International Application No. PCT/US2011/057754, 13 pages.
- International Search Report, PCT/US02/07661, Aug. 13, 2002, 5 Pages.
- International Search Report, PCT/US03/031339, Feb. 18, 2004, 3 Pages.
- International. Search Report, PCT/US01/044977, Jun. 7, 2002, 6 Pages.
- Non-Final Office Action dated Mar. 13, 2013, U.S. Appl. No. 13/560,942, 15 Pages.
- Notice of Allowance for U.S. Appl. No. 13/560,942, Dated Nov. 20, 2013, 11 pages.
Type: Grant
Filed: Nov 26, 2013
Date of Patent: Jan 31, 2017
Patent Publication Number: 20140148805
Assignee: Medtronic, Inc. (Minneapolis, MN)
Inventors: Mark T. Stewart (Lino Lakes, MN), David Francischelli (Anoka, MN), Rahul Mehra (Stillwater, MN), James Skarda (Lake Elmo, MN)
Primary Examiner: Jocelyn D Ram
Application Number: 14/091,055
International Classification: A61B 18/18 (20060101); A61B 18/14 (20060101); A61B 17/00 (20060101); A61B 18/00 (20060101);